Technology Stock Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19
SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ WuXi Vaccines, a world-leading vaccine Contract Development and Manufacturing Organization (CDMO), today announced it achieved the weather-tight construction milestone of its vaccine manufacturing facility currently under construction in Dundalk, Ireland, while the company demonstrated extraordinary resilience despite COVID-19 challenges. The facility is expected to be operational in 2022. The modular lab was already in GMP operations since July 2020.
WuXi Vaccines signed a 20-year vaccine manufacturing contract valued at approximately USD $3 billion with a global pharmaceutical company in February 2020, following the signing of the letter of intent in May 2019. To implement this landmark agreement, WuXi Vaccines invested USD $240 million to build its vaccine manufacturing facility in Dundalk, I ....

Chris Chen , Contract Development , Technology Stock Code , Manufacturing Organization , Wuxi Vaccines , Wuxi Biologics , Stock Code , Shanghai Hile Bio Technology , Wuxi Vaccine , Co Vid , கிறிஸ் சென் , ஒப்பந்த வளர்ச்சி , தொழில்நுட்பம் ஸ்டாக் குறியீடு , உற்பத்தி ஆர்கநைஸேஶந் , ஸ்டாக் குறியீடு , ஷாங்காய் ஹிலே உயிர் தொழில்நுட்பம் , தடுப்பு மருந்துகள் , இணை வித் ,